Fiscal Year Ending March 2026 Financial Results Summary [Japanese Standards] (Consolidated)

Performance Overview

For the fiscal year ending March 2026, consolidated net sales were 90.09 billion yen (up 8.7% YoY), with growth across all segments. Operating profit was 5.016 billion yen (up 18.7%), ordinary income was 5.528 billion yen (up 40.8%), and net income attributable to owners of the parent was 3.886 billion yen (up 74.4%), marking substantial profit growth. Notably, the increase in sales and profit in the CTC segment was significant, supported by exchange gains and extraordinary income. Earnings per share (EPS) stood at 166.71 yen.

Segment-wise Performance and Financial Position

Major segments reported sales of VCCS: 56.096 billion yen (up 0.2%), CTC: 19.610 billion yen (up 25.6%), FC & MD: 11.458 billion yen (up 3.9%), Incubation Center: 2.920 billion yen (up 977.7%). The financial position showed total assets of 89.358 billion yen (an increase of 13.079 billion yen from the previous term-end) and net assets of 60.341 billion yen (up 8.311 billion yen). The equity ratio was 67.4%. Cash flows included a positive cash flow from operating activities of 4.319 billion yen, outflows of 4.420 billion yen from investing activities, and outflows of 174 million yen from financing activities.

Dividend Policy and Outlook

The annual dividend for the fiscal year ending March 2026 is 56 yen (an increase from the previous year), with a dividend payout ratio of 33.6%. The earnings outlook for the fiscal year ending March 2027 projects net sales of 97.0 billion yen (up 7.7%), operating profit of 7.0 billion yen (up 39.5%), and net income attributable to owners of the parent of 4.5 billion yen (up 15.8%). The company assumes an exchange rate of 1 dollar = 150 yen and plans to increase sales and profits mainly through expanding orders in the CTC segment.